There are 2867 resources available
816P - Investigating surrogate endpoints (SE) for overall survival (OS) in first-line (1L) advanced melanoma: A pooled-analysis of immune checkpoint inhibitor (ICI) trials
Presenter: James Larkin
Session: Poster session 03
1500P - Radiochemotherapy with gemcitabine as a radiosensitizer in patients with soft tissue sarcomas
Presenter: Laura Schneider
Session: Poster session 11
817P - Nivolumab (NIVO) + relatlimab (RELA) vs NIVO in previously untreated metastatic or unresectable melanoma: Additional response outcomes from RELATIVITY-047
Presenter: F. Stephen Hodi
Session: Poster session 03
1089P - Hepcidin expression as a predictive biomarker for anti-PD1/PDL1 antibody monotherapy for advanced non-small cell lung cancer
Presenter: Masaki Yamamoto
Session: Poster session 15
818P - Phase II confirmatory study of cemiplimab (350mg IV Q3W) in patients with locally advanced or metastatic cutaneous squamous cell carcinoma (CSCC): Study 1540 Group 6
Presenter: Brett Hughes
Session: Poster session 03
1090P - HER2 copy number variation in non-small cell lung cancer (NSCLC)
Presenter: Marco Tagliamento
Session: Poster session 15
1502P - Heavy pre-treatment is associated with microbiome dysbiosis, reduced immune infiltration, and potential resistance to immune checkpoint inhibitors in metastatic sarcoma
Presenter: Qiyuan Bao
Session: Poster session 11